title: Management of tumor lysis syndrome: need for evidence-based guidelines.
authors.forename: James H
authors.initials: JH
authors.lastname: Feusner
authors.forename: A Kim
authors.initials: AK
authors.lastname: Ritchey
authors.forename: Susan L
authors.initials: SL
authors.lastname: Cohn
authors.forename: Amy L
authors.initials: AL
authors.lastname: Billett
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D004231:Diuresis; D019317:Evidence-Based Medicine / Q000458:organization & administration*; D006801:Humans; D008495:Medical Oncology / Q000379:methods; D010372:Pediatrics / Q000379:methods; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications* / Q000628:therapy; D012307:Risk Factors; D012492:Salts / Q000737:chemistry; D015275:Tumor Lysis Syndrome / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D014503:Urate Oxidase / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D012492:Salts; C469709:rasburicase; D014503:Urate Oxidase